Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,241
  • Shares Outstanding, K 15,762
  • Annual Sales, $ 36,350 K
  • Annual Income, $ -6,330 K
  • 60-Month Beta 1.27
  • Price/Sales 2.86
  • Price/Cash Flow N/A
  • Price/Book 4.01
Trade IRIX with:

Options Overview

Details
  • Implied Volatility 71.97%
  • Historical Volatility 26.11%
  • IV Percentile 6%
  • IV Rank 3.61%
  • IV High 298.43% on 03/23/21
  • IV Low 63.49% on 07/12/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 533
  • Open Int (30-Day) 545

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.16
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.06 +8.42%
on 07/19/21
7.40 -11.22%
on 06/30/21
-0.83 (-11.22%)
since 06/25/21
3-Month
6.06 +8.42%
on 07/19/21
8.97 -26.76%
on 04/30/21
-1.70 (-20.56%)
since 04/27/21
52-Week
1.60 +310.63%
on 12/21/20
9.71 -32.37%
on 04/27/21
+4.50 (+217.39%)
since 07/27/20

Most Recent Stories

More News
Dermatology Lasers Market 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Analysis, Revenue, Forecast Report

The global dermatology lasers market is projected to rise at a considerable pace driven by the increasing investments in product R&D. The presence of several large scale companies will have a huge impact...

IRIX : 6.53 (-0.31%)
Iridex: Q1 Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Tuesday reported a loss of $2 million in its first quarter.

IRIX : 6.53 (-0.31%)
Iridex Announces First Quarter 2021 Financial Results

Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021.

IRIX : 6.53 (-0.31%)
IRIDEX Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 11, 2021 / IRIDEX Corp. (NASDAQ:IRIX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 5:00 PM Eastern Time....

IRIX : 6.53 (-0.31%)
Ophthalmic Medical Lasers Global Market Report 2021: COVID 19 Growth And Change to 2030

Reportlinker.com announces the release of the report "Ophthalmic Medical Lasers Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06071075/?utm_source=GNW

CZMWF : 188.2500 (+0.40%)
IRIX : 6.53 (-0.31%)
TOPCF : 14.1000 (+0.71%)
Earnings Preview: Iridex (IRIX) Q1 Earnings Expected to Decline

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRIX : 6.53 (-0.31%)
Iridex to Report First Quarter 2021 Financial Results on May 11, 2021

Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial...

IRIX : 6.53 (-0.31%)
Iridex (IRIX) Beats on Q4 Earnings, Revenues Increase Y/Y

Iridex's (IRIX) fourth-quarter 2020 results benefit from strong product line-up and expanding market position.

AAPL : 147.21 (-1.19%)
ARW : 114.65 (-0.14%)
IRIX : 6.53 (-0.31%)
AMKR : 22.78 (-0.65%)
Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 90.91% and 0.40%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 6.53 (-0.31%)
Iridex: Q4 Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Monday reported a loss of $179,000 in its fourth quarter.

IRIX : 6.53 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

3rd Resistance Point 6.86
2nd Resistance Point 6.75
1st Resistance Point 6.65
Last Price 6.53
1st Support Level 6.44
2nd Support Level 6.33
3rd Support Level 6.23

See More

52-Week High 9.71
Fibonacci 61.8% 6.62
Last Price 6.53
Fibonacci 50% 5.66
Fibonacci 38.2% 4.70
52-Week Low 1.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar